Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | P-CD19CD20-ALLO1 |
Trade Name | |
Synonyms | |
Drug Descriptions |
Limited information is currently available on P-CD19CD20-ALLO1, a putative allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and CD20 (Aug 2023). |
DrugClasses | CD19 Immune Cell Therapy 62 CD20 Immune Cell Therapy 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
P-CD19CD20-ALLO1 | P-CD19CD20-ALLO1 | 0 | 1 |